Nippon Shinyaku Co., Ltd. (TYO:4516)

Market Cap	283.15B +13.5%
Revenue (ttm)	170.77B +6.6%
Net Income	29.72B -8.7%
EPS	441.00 -8.7%
Shares Out	67.40M
PE Ratio	9.53
Forward PE	10.18
Dividend	124.00 (2.95%)
Ex-Dividend Date	Mar 30, 2026

Volume	380,000
Open	4,140.00
Previous Close	4,090.00
Day's Range	4,140.00 - 4,245.00
52-Week Range	2,967.00 - 6,529.00
Beta	-0.30
Analysts	Hold
Price Target	5,457.14 (+29.9%)
Earnings Date	May 15, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1911
• Employees: 2,243
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4516

Financial Performance

In fiscal year 2026, Nippon Shinyaku's revenue was 170.77 billion, an increase of 6.58% compared to the previous year's 160.23 billion. Earnings were 29.72 billion, a decrease of -8.71%.